Ameriprise’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $548M | Buy |
19,519,056
+1,127,951
| +6% | +$30M | 0.13% | 174 |
|
|
2025
Q4 | $458M | Buy |
18,391,105
+17,965
| +0.1% | +$453K | 0.1% | 212 |
|
|
2025
Q3 | $468M | Buy |
18,373,140
+5,978,927
| +48% | +$148M | 0.11% | 203 |
|
|
2025
Q2 | $300M | Buy |
12,394,213
+689,780
| +6% | +$16.1M | 0.07% | 270 |
|
|
2025
Q1 | $297M | Sell |
11,704,433
-3,157,803
| -21% | -$82.6M | 0.08% | 252 |
|
|
2024
Q4 | $394M | Sell |
14,862,236
-5,299,962
| -26% | -$144M | 0.1% | 210 |
|
|
2024
Q3 | $584M | Buy |
20,162,198
+1,909,118
| +10% | +$55.7M | 0.15% | 153 |
|
|
2024
Q2 | $511M | Sell |
18,253,080
-287,124
| -2% | -$7.9M | 0.14% | 160 |
|
|
2024
Q1 | $515M | Sell |
18,540,204
-2,189,208
| -11% | -$60.7M | 0.14% | 159 |
|
|
2023
Q4 | $597M | Buy |
20,729,412
+8,223,229
| +66% | +$249M | 0.18% | 122 |
|
|
2023
Q3 | $413M | Sell |
12,506,183
-9,998,619
| -44% | -$354M | 0.14% | 163 |
|
|
2023
Q2 | $831M | Sell |
22,504,802
-855,359
| -4% | -$33.3M | 0.26% | 83 |
|
|
2023
Q1 | $950M | Buy |
23,360,161
+863,374
| +4% | +$37.3M | 0.31% | 71 |
|
|
2022
Q4 | $1.15B | Buy |
22,496,787
+262,117
| +1% | +$12.6M | 0.4% | 49 |
|
|
2022
Q3 | $973M | Buy |
22,234,670
+180,952
| +0.8% | +$8.79M | 0.36% | 58 |
|
|
2022
Q2 | $1.16B | Sell |
22,053,718
-560,926
| -2% | -$28.6M | 0.4% | 51 |
|
|
2022
Q1 | $1.17B | Buy |
22,614,644
+4,361,710
| +24% | +$226M | 0.34% | 59 |
|
|
2021
Q4 | $1.07B | Sell |
18,252,934
-404,892
| -2% | -$20.1M | 0.3% | 64 |
|
|
2021
Q3 | $802M | Buy |
18,657,826
+1,129,497
| +6% | +$50M | 0.26% | 80 |
|
|
2021
Q2 | $687M | Sell |
17,528,329
-412,007
| -2% | -$16M | 0.21% | 102 |
|
|
2021
Q1 | $650M | Buy |
17,940,336
+9,451,863
| +111% | +$336M | 0.22% | 98 |
|
|
2020
Q4 | $313M | Sell |
8,488,473
-9,697,086
| -53% | -$356M | 0.11% | 195 |
|
|
2020
Q3 | $633M | Sell |
18,185,559
-1,144,656
| -6% | -$40.1M | 0.26% | 79 |
|
|
2020
Q2 | $599M | Sell |
19,330,215
-1,807,790
| -9% | -$61.4M | 0.26% | 86 |
|
|
2020
Q1 | $655M | Sell |
21,138,005
-4,431,192
| -17% | -$151M | 0.34% | 57 |
|
|
2019
Q4 | $951M | Sell |
25,569,197
-660,239
| -3% | -$23.5M | 0.4% | 44 |
|
|
2019
Q3 | $894M | Sell |
26,229,436
-10,613,097
| -29% | -$386M | 0.4% | 45 |
|
|
2019
Q2 | $1.51B | Buy |
36,842,533
+706,765
| +2% | +$28.1M | 0.68% | 20 |
|
|
2019
Q1 | $1.46B | Sell |
36,135,768
-11,040,514
| -23% | -$442M | 0.67% | 22 |
|
|
2018
Q4 | $1.95B | Sell |
47,176,282
-8,574,002
| -15% | -$356M | 0.98% | 10 |
|
|
2018
Q3 | $2.41B | Sell |
55,750,284
-2,336,853
| -4% | -$90M | 0.84% | 12 |
|
|
2018
Q2 | $2B | Buy |
58,087,137
+289,423
| +0.5% | +$9.89M | 0.88% | 12 |
|
|
2018
Q1 | $1.95B | Sell |
57,797,714
-5,771,569
| -9% | -$198M | 0.88% | 12 |
|
|
2017
Q4 | $2.18B | Buy |
63,569,283
+493,682
| +0.8% | +$16.8M | 1% | 11 |
|
|
2017
Q3 | $2.14B | Buy |
63,075,601
+2,637,802
| +4% | +$84.8M | 1.02% | 9 |
|
|
2017
Q2 | $1.93B | Sell |
60,437,799
-1,742,791
| -3% | -$55M | 0.96% | 11 |
|
|
2017
Q1 | $2.02B | Sell |
62,180,590
-4,154,942
| -6% | -$131M | 1.04% | 9 |
|
|
2016
Q4 | $2.04B | Sell |
66,335,532
-2,934,131
| -4% | -$89.6M | 1.12% | 8 |
|
|
2016
Q3 | $2.23B | Buy |
69,269,663
+1,743,768
| +3% | +$58.3M | 1.25% | 5 |
|
|
2016
Q2 | $2.26B | Sell |
67,525,895
-1,619,803
| -2% | -$51.7M | 1.32% | 6 |
|
|
2016
Q1 | $1.94B | Buy |
69,145,698
+4,761,783
| +7% | +$136M | 1.16% | 6 |
|
|
2015
Q4 | $1.97B | Buy |
64,383,915
+7,324,102
| +13% | +$230M | 1.16% | 6 |
|
|
2015
Q3 | $1.7B | Buy |
57,059,813
+1,464,864
| +3% | +$47M | 1.05% | 8 |
|
|
2015
Q2 | $1.77B | Sell |
55,594,949
-694,343
| -1% | -$22.6M | 1.01% | 9 |
|
|
2015
Q1 | $1.86B | Buy |
56,289,292
+3,372,599
| +6% | +$107M | 1.07% | 5 |
|
|
2014
Q4 | $1.56B | Sell |
52,916,693
-6,081,971
| -10% | -$174M | 0.91% | 7 |
|
|
2014
Q3 | $1.66B | Sell |
58,998,664
-6,334,162
| -10% | -$178M | 1% | 8 |
|
|
2014
Q2 | $1.84B | Sell |
65,332,826
-912,614
| -1% | -$26M | 1.09% | 7 |
|
|
2014
Q1 | $2.02B | Buy |
66,245,440
+4,575,198
| +7% | +$136M | 1.21% | 4 |
|
|
2013
Q4 | $1.79B | Sell |
61,670,242
-1,832,338
| -3% | -$53.3M | 1.09% | 5 |
|
|
2013
Q3 | $1.73B | Sell |
63,502,580
-5,382,636
| -8% | -$146M | 1.13% | 5 |
|
|
2013
Q2 | $1.83B | Buy |
+68,885,216
| New | +$1.9B | 1.27% | 3 |
|
Other funds holding PFE
VCM
VPM
Ameriprise's PFE Position: Q1 2026 in Review
Ameriprise increased its Pfizer (PFE) stake by 6.1% in Q1 2026, buying an estimated $30M and bringing the position to 19,519,056 shares worth $548M. The position accounts for 0.13% of the portfolio, ranked #174.
Ameriprise first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.41B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Ameriprise held 19,519,056 shares of Pfizer worth $548M as of Q1 2026.
- Ameriprise bought 1,127,951 Pfizer shares in Q1 2026, an estimated $30M.
- Pfizer made up 0.13% of Ameriprise's portfolio in Q1 2026, its #174 holding.
- Ameriprise first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Pfizer position peaked at $2.41B in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.